查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198776

语音假体设备市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Voice Prosthesis Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在预测期内（2022-2027 年），语音假肢设备市场的复合年增长率为 5.6%。

COVID-19 爆发导致临床操作延误。这会在一定程度上影响市场增长。例如，根据 Smith & Nephew 于 2021 年 6 月发布的年度报告，ENT（耳鼻喉）设备公司，包括 Smith & Nephew 和 Cochlear Limited 等主要参与者，都经历了临床试验延迟。去年 COVID-19 影响了 ENT（耳鼻喉）设备市场，正如美国国家医学图书馆在 2020 年 8 月发布的题为“COVID-19 流行病对耳鼻喉手术量的影响”所公布的那样，共有 2840 万台手术已经完成在为期 12 週的 COVID-19 激增期间被推迟或取消。其中，230 万与癌症治疗或诊断有关。另一方面，良性疾病、骨科手术和耳鼻喉科的病例最常被推迟或取消。销售额下降主要是由于 COVID-19 的影响推迟了耳鼻喉科和骨盆矫形器。大流行前 2020 年的销售是由耳鼻喉手术导航系统、术中 NIM 神经监测系统和动力耳鼻喉仪器的固定设备销售推动的。因此，COVID-19 对市场增长产生了重大影响。

推动语音假体设备市场增长的主要因素是导致喉咙痛和耳痛的喉癌患者的全球患病率上升。

例如，根据NIDCD（National Institute on Deafness and Other Communication Disorders） 2020 年的更新，美国约有 750 万人患有与声音相关的问题。此外，政府增加医疗保健支出以及製造商定制假体发声设备尺寸以提高患者依从性、减少说话费力和有效发挥功能的研发活动导致假体发声设备的增加。它将激活世界市场。

除此之外，语音假体设备市场受到喉癌病例数量增加的推动。喉癌是一种在喉部组织中形成癌细胞并导致喉咙痛和耳痛的疾病。根据 2022 年 2 月的 Cancer.net 更新，喉癌是一种众所周知的头颈癌。到 2022 年，美国估计将有 12,470 名成年人（9,820 名男性和 2,650 名女性）被诊断出患有喉癌。这种疾病的流行率每年以大约 2% 到 3% 的速度下降。

此外，Atos 将于 2021 年 7 月成立 Heimomed Heinze GmbH & Co.KG，这是一家生产高质量气管切开产品的医疗技术公司。通过此次收购，Atos 扩大了其在德国和奥地利的业务并支持市场增长。此外，2021 年 10 月，Freudenberg Medical 推出了革命性的免说话 HME 阀，用于喉切除术护理。

然而，非常高的製造设备成本、发音假体设备的高价格以及设备的短寿命（大约 3-6 个月）可能会阻碍发音假体设备市场的增长。

人工耳蜗市场趋势

植入式语音修復设备市场预计将在预测期内占据主要份额

在人工发音设备市场中，家用人工发音领域有望占据较大份额。该行业的增长受到人口老龄化和技术进步的推动，这些技术进步使设备功能更加高效，包括更长的预期寿命、更好的患者对手术的依从性以及包括门诊更换在内的维护。此外，由于它具有低空气阻力并且可以最佳地附着在气管食管壁上，因此越来越多地选择留置人工声带，这有助于增加人工声带的全球市场份额。

医疗技术公司已经为喉切除术后的成年人提供内置人工语音，以实现口头交流并取得高临床疗效。留置发声假体已获得临床认可，可用于患者的发声康復，尤其是喉癌和下嚥癌患者。

例如，根据 2020 年 2 月发表的一项题为“喉癌流行病学更新”的研究，目前喉癌的发病率和患病率分别为每 10 万人 2.76 例/年，估计为每 10 万人 14.33 例/年人口，平均每年 328 万残疾调整生命年。在过去 30 年中，发病率和患病率分别增加了 12% 和 24%。此外，根据 GLOBOCAN 于 2020 年更新的统计数据，2020 年喉癌新发病例数为 185,000 例，预计到 2040 年将增至 284,000 例。因此，全球喉癌病例数量的增加正在推动对内置语音助听器的需求，预计这将在预测期内进一步加速该细分市场的增长。

此外，根据 2022 年 3 月发表的一项题为“印度喉切除者的语音假体体验”的研究。根据 2022 年 3 月发表的一项题为“印度南部一家三级医院的初步调查结果”的研究，此外，非集成和集成语音假体之间的成本差异是选择语音假体的主要驱动力。。因此，由于留置人工耳蜗的主导地位，预计该细分市场将在预测期内扩大。

预计对语音修復设备的需求不断增长将有助于留置语音修復设备细分市场的增长。留置式语音助听器因其技术简单而需求量很大，可提高语音质量和患者满意度。

因此，由于上述因素，研究部门有望为市场的显着增长做出贡献。

北美主导语音假体设备市场，预计在预测期内也会如此

在整个预测期内，北美预计将主导整个 VPD 市场。这一优势主要归因于气管切开术癌症发病率的增加、医疗保健支出的增加以及先进医疗保健基础设施的可用性。例如，根据美国癌症协会2022年1月的最新估计，2022年美国约有12470例喉癌新发病例，其中男性9820例，女性2650例。此外，根据GLOBOCAN 2020年更新的统计数据，2020年美国将新增12600例喉癌病例，预计到2040年美国将增加至最多15700例。因此，该地区喉癌病例的增加预计会增加语音修復设备的采用。因此，预计该地区在预测期内将经历快速的市场扩张。

此外，正在进行多种类型的研究活动，各种公共和私人研究机构正在与製造商合作，这有望推动语音假体市场。

因此，由于上述因素，预计所研究的市场将导致北美市场的利润丰厚的增长。

发声器市场竞争者分析

全球语音假肢市场竞争适中，由几家主要参与者组成。目前在市场份额方面占据市场主导地位的一些知名企业已与其他公司建立合作伙伴关係，以获取产品并加强其在全球的市场地位，而其他公司则在分销产品。目前主导市场的公司包括 Andreas Fahl Medizintechnik-Vertrieb GmbH、InHealth Technologies、Atos Medical AB、Servona GmbH、Teleflex Incorporated 和 Smiths Medical。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第 1 章 简介

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第三章执行摘要

第四章市场动态

  • 市场概况
  • 市场驱动力
    • 老年人口增加和医疗报销增加
    • 由于癌症患者的增加，对语音假体的需求增加
  • 市场製约因素
    • 语音修復设备的高采购和维护成本
    • 设备寿命短，缺乏患者可用性和接受度
  • 波特五力分析
    • 新进入者的威胁
    • 买方议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争对手之间的竞争

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按设备
    • 非植入式人工发音装置
    • 植入式人工发音装置
  • 按最终用户
    • 医院
    • 诊所
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 欧洲其他地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太其他地区
  • 世界其他地区

第六章竞争格局

  • 公司简介
    • Andreas Fahl Medical Technology Sales GmbH
    • InHealth Technologies
    • Atos Medical AB
    • Servona GmbH
    • ICU Medical Inc（Smiths Medical）
    • Teleflex Incorporated
    • HEIMOMED Heinze
    • Hood Laboratories
    • Karl Storz Gmbh & Co. Kg

第七章市场机会与未来趋势

简介目录
Product Code: 67694

The voice prosthesis devices market is projected to register a CAGR of 5.6% during the forecast period (2022 - 2027).

The outbreak of COVID-19 had led to delays in clinical operations. This can impact the market growth to a certain extent. For instance, as per the annual report of Smith & Nephew published in June 2021 ENT (Ear, Nose, Throat) device companies, including major players, such as Smith & Nephew and Cochlear Limited, saw clinical trial delays. As per the National Library of Medicine in August 2020, titled "Impact of the COVID-19 epidemic on ENT surgical volume" COVID-19 had an impact on the ENT (Ear, Nose, Throat) devices market last year, with a total of 28.4 million operations have been postponed or canceled during the 12-week COVID-19 surge. Of these cases, 2.3 million were related to cancer treatment or diagnosis. The case types that were most likely to be postponed or delayed were those related to benign diseases, orthopedic, or ENT (Ear, Nose, Throat). The net sales witnessed a decline, which was primarily caused by the postponed procedures across both ENT and Pelvic Health, as a result of COVID-19. Before the pandemic's impact, the fiscal year 2020 sales were driven by capital equipment sales of the ENT surgical navigation system, intraoperative NIM nerve monitoring system, and powered ENT instruments. Thus, COVID-19 had a significant impact on the growth of the market.

The major factors attributing to the growth of the Voice Prosthesis Devices market are the rise in the global prevalence of larynx cancer cases which results in sore throat and ear pain.

For instance, according to the NIDCD (National Institute on Deafness and Other Communication Disorders) updated in 2020, about 7.5 million people in the United States suffered from voice-related problems. Also, the increase in government expenditure for healthcare, and R&D activities by the manufacturers to customize the Voice Prosthesis Devices size to enhance patient compliance, lesser effort to speak and efficient functioning will fuel the global Voice Prosthesis Devices market.

In addition to this, the voice prosthesis device and equipment market is driven by an increasing number of cases of larynx cancer. Larynx cancer is a disease in which cancer cells form tissue in the larynx and cause a sore throat and ear pain. As per Cancer.net updates from February 2022, laryngeal cancer is a common type of head and neck cancer. In 2022, an estimated 12,470 adults (9,820 men and 2,650 women) in the United States will be diagnosed with laryngeal cancer. The incidence rates of this disease are decreasing by around 2% to 3% annually.

Moreover, in July 2021, Atos acquired Heimomed Heinze GmbH & Co. KG, a med-tech company that manufactures high-quality tracheostomy products. With this acquisition, Atos expands its footprint in Germany and Austria, thus fueling the market growth. Additionally, in October 2021, Freudenberg Medical Launched Breakthrough SpeakFree HME Valve for Laryngectomy Care.

However, highly expensive equipment for manufacture, prices of voice prosthesis devices, and shorter life span of the devices only about 3-6 months are likely to impede the voice prosthesis devices market growth.

Voice Prosthesis Devices Market Trends

In-Dwelling Voice Prosthesis Devices Segment is Expected to Hold the Major Market Share Over the Forecast Period

The in-dwelling voice prosthesis devices segment is expected to account for a large share of the voice prosthesis devices market. The growth of the segment can be attributed to the rising geriatric population and technological advancements which enhanced the efficiency of device functioning such as prolonged lifetime, and improved patient compliance to operating, and maintenance including outpatient replacements. Also, due to their ability to have low air resistance and optimal retention in the tracheoesophageal wall, the preference for the Indwelling voice prosthesis devices has been increased and thus, contributes to their share in the global voice prosthesis devices market.

Medical technology companies have been offering indwelling voice prostheses for adults following the total laryngectomy to enable them to communicate verbally with high clinical outcomes. in-dwelling voice prosthesis devices are gaining clinical acceptance for speech rehabilitation in patients, especially in patients with laryngeal and hypopharyngeal cancer.

For instance, as per the study published in February 2020, titled "Updates on larynx cancer epidemiology", the current incidence and prevalence of laryngeal cancer are estimated at 2.76 cases/year per 100,000 inhabitants, and 14.33 cases/year per 100,000 inhabitants, respectively, averaging 3.28 million DALYs each year. Incidence and prevalence have increased by 12% and 24%, respectively during the past 3 decades. Furthermore, as per the statistics updated in 2020 by the GLOBOCAN the estimated number of new cases of Laryngeal cancer was 185,000 in 2020 which is expected to increase and reach up to 284,000 by 2040 globally. Thus, the increasing cases of laryngeal cancer worldwide are expected to increase the demand for in-dwelling voice prosthesis devices which will further surge the growth of the segment over the forecast period.

Additionally, as per the study published in March 2022, titled "Voice prosthesis experience of Indian laryngectomees: Preliminary findings from a tertiary hospital in South India", besides, the difference in the cost between nonindwelling and indwelling voice prostheses is a major driving factor in opting for it. Thus, due to the advantage offered by the in-dwelling voice prosthesis device, the market segment is expected to increase over the forecast period.

The rise in demand for voice prosthesis devices is likely to contribute to the growth of the indwelling voice prosthesis device segments. Demand for indwelling voice prosthesis devices is high due to their technical simplicity, leading to improvement in voice quality and patient satisfaction.

Thus, due to the above-mentioned factors, the studied segment is expected to contribute to the significant growth of the market.

North America Dominates the Voice Prosthesis Devices Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall VPD market throughout the forecast period. This dominance is mainly owing to the increased incidence of tracheostomy cancers along with the increased healthcare expenditure and availability of advanced healthcare infrastructure. For instance, the American Cancer Society's most recent January 2022, estimates for laryngeal cancer in the United States in 2022, about 12,470 new cases of laryngeal cancer are estimated to be 9,820 in men and 2,650 in women. Furthermore, as per the statistics updated in 2020 by the GLOBOCAN, the estimated number of new cases of Laryngeal cancer was 12,600 in 2020 which is expected to increase and reach up to 15,700 by 2040 in the United States. Thus the increase in laryngeal cancer cases in the region is expected to increase the adoption of voice prosthesis devices. Thereby, the market is expected to surge in the region over the forecast period.

Furthermore, several types of research activities are going on and various public and private research institutes collaborated with the manufacturers, which is expected to drive the voice prosthesis devices market.

Therefore, due to the above-mentioned factors, the studied market is expected to lead to lucrative growth of the market in North America.

Voice Prosthesis Devices Market Competitor Analysis

The global voice prosthesis devices market is moderately competitive and consists of several major players. Some prominent players that are currently dominating the market In terms of market share are acquiring the products, entering into partnerships with the other companies to consolidate their market positions across the globe and while others are distributing products. Some of the companies which are currently dominating the market are Andreas Fahl Medizintechnik-Vertrieb GmbH, InHealth Technologies, Atos Medical AB, Servona GmbH, Teleflex Incorporated, and Smiths Medical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapidly Growing Geriatric Population along with Rise in Healthcare Reimbursements
    • 4.2.2 Increasing Demand for Voice Prosthetics with Rise in Cancer Cases
  • 4.3 Market Restraints
    • 4.3.1 High Procurement and Maintenance Costs of Voice Prosthesis Devices
    • 4.3.2 Shorter Lifespan of the Devices along with Lack of Availability and Acceptance by the Patients
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Devices
    • 5.1.1 Non-dwelling Voice Prosthesis Devices
    • 5.1.2 In-dwelling Voice Prosthesis Devices
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Clinics
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
  • 5.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Andreas Fahl Medical Technology Sales GmbH
    • 6.1.2 InHealth Technologies
    • 6.1.3 Atos Medical AB
    • 6.1.4 Servona GmbH
    • 6.1.5 ICU Medical Inc (Smiths Medical)
    • 6.1.6 Teleflex Incorporated
    • 6.1.7 HEIMOMED Heinze
    • 6.1.8 Hood Laboratories
    • 6.1.9 Karl Storz Gmbh & Co. Kg

7 MARKET OPPORTUNITIES AND FUTURE TRENDS